How Does Metronidazole Work in the Body

Chemical Composition, Mechanism of Action & Metabolic Effects Explained

Key Takeaways: How Metronidazole Works

  • Class: Nitroimidazole antibiotic
  • Target: Anaerobic bacteria and protozoa
  • Mechanism: Enters bacterial cells, activated by reduction, then damages DNA
  • Selectivity: Only affects anaerobes (they have the enzymes to activate it)
  • Metabolism: Liver (CYP enzymes), half-life ~8 hours
  • Key precaution: Absolutely no alcohol during treatment and for 48 hours after

Metronidazole is a widely used antibiotic that specifically targets anaerobic bacteria and certain parasites. Understanding how it works helps you appreciate why it’s prescribed for conditions like bacterial vaginosis, dental infections, and infected leg ulcers.

Important Medical Advice

If you experience swelling of the face, lips or throat, difficulty breathing, severe skin rash, or signs of a serious allergic reaction, stop taking metronidazole and seek immediate medical help. Do not drink alcohol while taking this medicine and for 48 hours after finishing – it can cause severe nausea, vomiting, and flushing.

Chemical Composition & Molecular Structure of Metronidazole

Metronidazole is a synthetic nitroimidazole derivative. Its chemical structure is key to its selective toxicity against anaerobic organisms.

Chemical Structure Details

Chemical Name

2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethanol

The nitro group (-NO₂) at position 5 is essential for antibacterial activity.

Molecular Formula

C₆H₉N₃O₃

Contains 6 carbon, 9 hydrogen, 3 nitrogen and 3 oxygen atoms.

Molecular Weight

171.15 g/mol

Low molecular weight facilitates diffusion into bacterial cells.

Key Pharmaceutical Properties

PropertyValue/CharacteristicClinical Significance
SolubilitySlightly soluble in water, soluble in alcoholGood oral absorption, can be given IV if needed
pKa2.5 (weak base)Remains non‑ionised at physiological pH, crosses membranes easily
Protein Binding<20% bound to plasma proteinsLow binding means high free fraction available for tissue penetration

🗒️ Pharmaceutical Insight: The 5-nitro group is a pro-moiety that becomes active only after reduction inside anaerobic organisms. This design ensures minimal effect on human cells or aerobic bacteria.

Mechanism of Action: How Metronidazole Kills Bacteria

Metronidazole is a prodrug that requires activation by susceptible organisms. Here’s the step‑by‑step process:

  1. Penetration: Metronidazole diffuses passively into bacterial cells (both aerobic and anaerobic) because it is small and uncharged.
  2. Selective activation: In anaerobic bacteria and protozoa, intracellular electron‑transport proteins (e.g., ferredoxin, nitroreductases) transfer electrons to the nitro group of metronidazole, reducing it.
  3. Toxic intermediates: This reduction produces highly reactive nitro radical anions and other cytotoxic compounds.
  4. DNA damage: These intermediates interact with bacterial DNA, causing helix destabilisation, strand breakage, and inhibition of nucleic acid synthesis.
  5. Cell death: The cumulative damage leads to rapid cell death of the microorganism.

Why it doesn’t work on aerobes

Aerobic bacteria lack the necessary reduction systems (low redox potential) to activate metronidazole. Therefore, the drug remains inactive inside them, explaining its narrow spectrum.

🗒️ Biological Insight: Think of metronidazole as a “Trojan horse” – harmless until it enters an anaerobic environment where the bacterial machinery unwittingly turns it into a potent weapon against itself.

Metabolic Effects & Duration of Metronidazole

After absorption, metronidazole is extensively metabolised in the liver, primarily by CYP2C9 and CYP3A4 enzymes. Its pharmacokinetics determine dosing frequency.

Metabolic Pathway

Primary Metabolism

Location: Liver (oxidation and glucuronidation)

Process: Side‑chain oxidation and nitro reduction

Result: Hydroxy metabolite (active) and acid metabolite (inactive)

Elimination

Half-life: 6‑8 hours (normal liver function)

Excretion: 60‑80% in urine (as metabolites and unchanged drug), 6‑15% in faeces

Special Population Considerations

PopulationEffect on MetronidazoleDosing Consideration
Severe liver impairmentReduced clearance, increased half‑lifeLower dose or extended interval; monitor for toxicity
Kidney dialysisRemoves drug and metabolitesDose after dialysis session
ElderlyPharmacokinetics similar, but monitor renal functionStandard dosing, but caution with comorbidities

🗒️ Clinical Correlation: The 8‑hour half‑life supports three‑times‑daily dosing for most infections. Accumulation can occur in severe liver disease – your doctor may adjust your dose.

Absorption, Distribution & Elimination of Metronidazole

Pharmacokinetic Profile

Absorption

Bioavailability: >90% after oral dose

Peak time: 1‑2 hours (fasting)

Food effect: Slightly delayed but total absorption unchanged

Distribution

Volume: 0.5‑0.8 L/kg – wide distribution

Tissue penetration: Excellent: crosses blood‑brain barrier, placenta, enters abscesses, bone, and vaginal secretions

Elimination

Clearance: Hepatic and renal

Urine: Mostly as metabolites; turns urine dark reddish‑brown (harmless)

Because metronidazole distributes so widely, it is effective in deep‑seated infections like brain abscess, pelvic inflammatory disease, and bone infections.

Clinical Efficacy & Common Uses of Metronidazole

Metronidazole is the drug of choice for many anaerobic and protozoal infections. According to the PIL, it is used for:

  • Infections of the blood, brain, lung, bones, genital tract, pelvic area, stomach and intestines
  • Infected leg ulcers and pressure sores
  • Prevention of infections after surgery
  • Bacterial vaginosis (most common cause of abnormal vaginal discharge)
  • Dental infections (acute ulcerative gingivitis, pericoronitis)

Efficacy rates

For BV, cure rates exceed 80% with a 5‑7 day course. For anaerobic abscesses, it is often life‑saving. It also treats Clostridium difficile‑associated diarrhoea (though oral vancomycin is now first‑line for severe cases).

Important Safety Precautions & Warnings

Based on the PIL and MHRA guidance, be aware of these critical points:

  • Alcohol: Do not drink alcohol during treatment and for 48 hours after – can cause disulfiram‑like reaction (flushing, headache, nausea, vomiting).
  • Neurological effects: If you experience numbness, tingling, or weakness in limbs, or CNS symptoms (seizures, confusion), stop the medicine and tell your doctor immediately.
  • Serious skin reactions: Stevens‑Johnson syndrome, toxic epidermal necrolysis, and acute generalised exanthematous pustulosis have been reported. Stop at first sign of rash.
  • Cockayne syndrome: Patients with this rare genetic disorder are at risk of severe liver toxicity; frequent liver monitoring is required.
  • Drug interactions: Warfarin (increased bleeding risk), lithium (toxicity), phenytoin, phenobarbital, 5‑fluorouracil, busulfan, ciclosporin, disulfiram.
  • Pregnancy and breastfeeding: Use only if clearly necessary; small amounts pass into breast milk – discuss with your doctor.

Seek urgent help if you develop: yellow skin/eyes (jaundice), severe stomach pain, mouth ulcers, unexplained bruising or bleeding, or vision problems.

Metronidazole Mechanism FAQs

You may feel improvement within 24‑48 hours, but it’s vital to complete the full course (usually 5‑7 days) to prevent resistance.

No. Alcohol can cause severe nausea, vomiting, flushing and rapid heartbeat. Avoid alcohol during treatment and for 48 hours after your last dose.

It mainly targets anaerobic bacteria, so it spares most aerobic gut flora. However, it can still disturb gut balance – probiotics may help.

A harmless side effect – it’s due to coloured metabolites excreted in urine. It’s not dangerous and goes away after stopping the medicine.

Your doctor will weigh risks and benefits. It’s generally avoided in the first trimester unless absolutely necessary. Always consult your GP.

Need Treatment with Metronidazole?

If you think you have bacterial vaginosis or another anaerobic infection, a UK‑registered doctor can help. Start an online consultation today.

Secure Prescription & Next-Day Delivery

MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors

Start BV Consultation
Nabeel M. - Medical Content Manager at Chemist Doctor
Authored byNabeel M.

Medical Content Manager

Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.

Usman Mir - Superintendent Pharmacist
Approved byUsman Mir

Medical Director

Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 26 February 2026

Next Review: 26 August 2026

Published on: 26 February 2026

Last Updated: 26 February 2026